Basecamp Wealth Advisors’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$15.7M Sell
13,577
-901
-6% -$1.06M 3.59% 5
2026
Q2
$17.4M Buy
14,478
+4
+0% +$4.09K 3.23% 4
2026
Q1
$13.3M Buy
14,474
+31
+0.2% +$31.4K 2.75% 7
2025
Q4
$15.5M Buy
+14,443
New +$13.8M 3.31% 5

Other funds holding LLY

Basecamp Wealth Advisors's LLY Position: Q3 2026 in Review

Basecamp Wealth Advisors reduced its Eli Lilly (LLY) stake by 6.2% in Q3 2026, selling an estimated $1.06M and leaving 13,577 shares worth $15.7M. The position accounts for 3.59% of the portfolio, ranked #5.

Basecamp Wealth Advisors first reported a position in LLY in Q4 2025 and has held it in 4 quarters since. The position peaked at $17.4M in Q2 2026. 4,568 funds tracked by Wall St. Rank hold LLY as of Q3 2026.

  • Basecamp Wealth Advisors held 13,577 shares of Eli Lilly worth $15.7M as of Q3 2026.
  • Basecamp Wealth Advisors sold 901 Eli Lilly shares in Q3 2026, an estimated $1.06M.
  • Eli Lilly made up 3.59% of Basecamp Wealth Advisors's portfolio in Q3 2026, its #5 holding.
  • Basecamp Wealth Advisors first reported a position in Eli Lilly in Q4 2025 and has held it in 4 quarters since.
  • Basecamp Wealth Advisors's Eli Lilly position peaked at $17.4M in Q2 2026.
  • 4,568 funds tracked by Wall St. Rank held Eli Lilly as of Q3 2026.

Based on Basecamp Wealth Advisors's 13F filing for Q3 2026, filed 16 Nov 2026.